Blockchain Registration Transaction Record
HeartBeam Appoints CEO Robert Eno to Board of Directors for Commercial Launch of 3D ECG Technology
HeartBeam (NASDAQ: BEAT) appoints CEO Robert Eno to Board of Directors for the launch of 3D ECG technology pending FDA clearance. Learn how their innovative approach could transform cardiac care outside medical facilities.

This news matters as it highlights the advancements in personalized cardiac care by HeartBeam, showcasing innovative technology that could redefine how cardiac health is managed. The appointment of CEO Robert Eno signifies a strategic move towards commercializing their groundbreaking 3D ECG technology, potentially impacting the future of cardiac care for patients and physicians alike.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x5227b9ea93644d34b71bd9bc24880de2a3ae10ddd71491258482832754645610 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | bestCsBh-1da466ddb31a48247a757cc5f315e614 |